B
Benjamin K. Law
Researcher at Broad Institute
Publications - 6
Citations - 69
Benjamin K. Law is an academic researcher from Broad Institute. The author has contributed to research in topics: CRISPR & Genome editing. The author has an hindex of 3, co-authored 4 publications receiving 37 citations. Previous affiliations of Benjamin K. Law include Harvard University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Engineering designer beta cells with a CRISPR-Cas9 conjugation platform.
Donghyun Lim,Donghyun Lim,Donghyun Lim,Vedagopuram Sreekanth,Vedagopuram Sreekanth,Vedagopuram Sreekanth,Kurt J. Cox,Kurt J. Cox,Kurt J. Cox,Benjamin K. Law,Benjamin K. Law,Benjamin K. Law,Bridget K. Wagner,Jeffrey M. Karp,Amit Choudhary,Amit Choudhary,Amit Choudhary +16 more
TL;DR: In this paper, site-specific and multiple-site conjugation of a wide assortment of molecules on both the termini and internal sites of Cas9, creating a platform for endowing Cas9 with diverse functions, using this platform, Cas9 can be modified to more precisely incorporate exogenously supplied singlestranded oligonucleotide donor (ssODN) at the DNA break site.
Journal ArticleDOI
A Singular System with Precise Dosing and Spatiotemporal Control of CRISPR‐Cas9
Debasish Manna,Debasish Manna,Debasish Manna,Basudeb Maji,Basudeb Maji,Basudeb Maji,Soumyashree A. Gangopadhyay,Soumyashree A. Gangopadhyay,Soumyashree A. Gangopadhyay,Kurt J. Cox,Qingxuan Zhou,Benjamin K. Law,Ralph Mazitschek,Amit Choudhary,Amit Choudhary,Amit Choudhary +15 more
TL;DR: By photocaging this Cas9 activator to render it biologically inert and photoactivatable, and employing next-generation protein engineering approaches, this work has built a system with a wide dynamic range, low background, and fast photoactivation using a low-intensity light while rendering the small-molecule activator biologically inert.
Journal ArticleDOI
Chemogenetic System Demonstrates That Cas9 Longevity Impacts Genome Editing Outcomes.
Vedagopuram Sreekanth,Vedagopuram Sreekanth,Vedagopuram Sreekanth,Qingxuan Zhou,Qingxuan Zhou,Qingxuan Zhou,Praveen Kokkonda,Praveen Kokkonda,Praveen Kokkonda,Heysol C Bermudez-Cabrera,Heysol C Bermudez-Cabrera,Donghyun Lim,Donghyun Lim,Donghyun Lim,Benjamin K. Law,Benjamin K. Law,Benjamin K. Law,Benjamin Holmes,Benjamin Holmes,Santosh K. Chaudhary,Santosh K. Chaudhary,Santosh K. Chaudhary,Rajaiah Pergu,Rajaiah Pergu,Rajaiah Pergu,Brittany S. Leger,James A. Walker,David K. Gifford,Richard I. Sherwood,Richard I. Sherwood,Richard I. Sherwood,Amit Choudhary,Amit Choudhary,Amit Choudhary +33 more
TL;DR: A chemogenetic system is developed that brings Cas9 in proximity to a ubiquitin ligase, enabling rapid ubiquitination and degradation of Cas9 by the proteasome, and is able to dosably control the Cas9 activity and specificity to ameliorate the off-target effects.
Journal ArticleDOI
A general approach to identify cell-permeable and synthetic anti-CRISPR small molecules
Donghyun Lim,Qingxuan Zhou,Kurt J. Cox,Benjamin K. Law,Miseon Lee,Praveen Kokkonda,Vedagopuram Sreekanth,Rajaiah Pergu,S. K. Chaudhary,Soumyashree A. Gangopadhyay,Basudeb Maji,Sophia Lai,Yuka Amako,David B. Thompson,Hari K. K. Subramanian,Michael F. Mesleh,Vlado Dančík,Paul A. Clemons,Bridget K. Wagner,Christina M. Woo,George M. Church,Amit Choudhary +21 more
Posted ContentDOI
A conjugation platform for CRISPR-Cas9 allows efficient β-cell engineering
Donghyun Lim,Donghyun Lim,Donghyun Lim,Vedagopuram Sreekanth,Vedagopuram Sreekanth,Vedagopuram Sreekanth,Kurt J. Cox,Kurt J. Cox,Kurt J. Cox,Benjamin K. Law,Benjamin K. Law,Benjamin K. Law,Bridget K. Wagner,Jeffrey M. Karp,Amit Choudhary,Amit Choudhary,Amit Choudhary +16 more
TL;DR: It is demonstrated that the multivalent display of ss ODN on Cas9 significantly increased precision genome edits over those of Cas9 bearing one or no ssODN, and such display platform is compatible with large oligonucleotides and rapid screening of ssODNs.